Abstract' Content and GPs' Confidence in the Conclusion
ACOPI
Impact of Reporting Funding Sources and Conflicts of Interest in RCTs' Abstracts on General Practitioners' Confidence: a 3-arms Randomized Controlled Trial.
1 other identifier
interventional
354
1 country
1
Brief Summary
Objective: The aim of this study is to assess the impact of reporting, in abstracts of randomized controlled trials, 1) the funding sources and 2) the conflicts of interest (COIs) of the authors on General Practitioners' confidence in the abstracts' conclusions. Design: Randomized Controlled Trial in 3 arms. Participants: General Practitioners (GP). They will be recruited among residents from the Primary Care department of the Paris Descartes University and among a GP network who agreed to participate to research studies. The allocation of participants will be done by a computerized randomization list, the sequence will be created by an independent statistician with a ratio 1: 1: 1. Participants will be blind of the hypothesis and of the randomization. Allocation concealment will be provided because only the statistician will have access to the randomization list. Methods: Three interventions will be assessed corresponding to three different types of abstracts: 1) abstracts not reporting neither the funding sources neither COIs of authors, 2) abstracts reporting funding sources and 3) abstracts reporting funding sources and COIs of authors. A sample of abstracts will be selected from published randomized trials, testing superiority, assessing pharmacological treatment, in the field of Primary Care and General Practice and having a conclusion in favor of the beneficial effect of experimental treatment in terms of tolerance and / or efficacy. They will then be standardized and modified to obtain three types of abstracts: 1) with funding sources, 2) with funding sources and COIs and 3) without either source of funding or COIs. Participants will be asked to assess one abstract of their randomization arm. Outcome: The primary endpoint will be the GPs' confidence in conclusions. The secondary endpoints will be the quality perception of the study and the interpretation of the benefit of experimental treatment. Responses will be ranged by a 10-point numeric scale. Potential interests: This study takes place in the field of Primary Care. We believe that better understandings of impact of funding sources and conflicts of interests are necessary to allow more transparency in medical research and in his translation into medical practice. Sample size expected: 354 participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2012
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 30, 2012
CompletedFirst Posted
Study publicly available on registry
September 6, 2012
CompletedStudy Start
First participant enrolled
October 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2013
CompletedDecember 23, 2013
December 1, 2013
Same day
July 30, 2012
December 20, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
GPS' confidence on the conclusion of the abstract
measure on a numeric scale frome 0 to 10 where 0 is "no confidence" and 10 is "full confidence"
30 days
Secondary Outcomes (2)
GPs' quality perception of the study
30 days
GPs' interpretation of the benefit of experimental treatment
30 days
Study Arms (3)
Control group
PLACEBO COMPARATORAssess abstract not reporting funding sources or conflicts of interest
Funding sources
EXPERIMENTALAssess one type of abstract in the randomized arm. Assess abstract reporting funding sources only.
Funding sources/Conflicts of Interests
EXPERIMENTALAssess one type of abstract in the randomized arm. Assess abstract reporting funding sources and conflicts of interest
Interventions
Participants will be asked to assess only one abstract in his arm of randomization. Three reminders will be made
Eligibility Criteria
You may qualify if:
- General practitioners
You may not qualify if:
- no one
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre d'Epidemiologie Clinique, Assistance Publique, Hotel Dieu
Paris, France, 75004, France
Related Publications (1)
Buffel du Vaure C, Boutron I, Perrodeau E, Ravaud P. Reporting funding source or conflict of interest in abstracts of randomized controlled trials, no evidence of a large impact on general practitioners' confidence in conclusions, a three-arm randomized controlled trial. BMC Med. 2014 Apr 28;12:69. doi: 10.1186/1741-7015-12-69.
PMID: 24779384DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Celine Buffel du Vaure
Hotel Dieu Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident
Study Record Dates
First Submitted
July 30, 2012
First Posted
September 6, 2012
Study Start
October 1, 2012
Primary Completion
October 1, 2012
Study Completion
January 1, 2013
Last Updated
December 23, 2013
Record last verified: 2013-12